This association was significantly larger in tumor BRCA1-PM patients, as was reflected by a significant interaction term between sTILs and tumor BRCA1-PM (HRinteraction, 0.82; 95% CI, 0.68–0.98). This evidence concerns the gene BRCA1 and neoplasm.